Ferulic acid inhibits endothelial cell proliferation through NO down-regulating ERK1/2 pathway

Journal of Cellular Biochemistry

Volumn 93, Issue 6, 2004, Pages 1203-1209

  Hou, YongZhong ^a   Yang, Jie ^a   Zhao, GuangRong ^a   Yuan, YingJin ^a  

^a TIANJIN UNIVERSITY   (China)

Author keywords

Cell cycle regulatory proteins; Extracellular signal regulated kinase; Human umbilical vein endothelial cells; Nitric oxide

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ARGININE DERIVATIVE; CYCLIN D1; ESTER DERIVATIVE; FERULIC ACID; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM; PROTEIN P21; RETINOBLASTOMA PROTEIN; COUMARIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; NITRITE; NONSTEROID ANTIINFLAMMATORY AGENT; STRESS ACTIVATED PROTEIN KINASE;

ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; DOWN REGULATION; DRUG EFFECT; DRUG INHIBITION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UMBILICAL VEIN; CELL CULTURE; CELL CYCLE; DRUG ANTAGONISM; ENZYME ACTIVATION; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PHOSPHORYLATION; SIGNAL TRANSDUCTION; UMBILICAL CORD; VASCULAR ENDOTHELIUM;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL CYCLE; CELL PROLIFERATION; CELLS, CULTURED; COUMARIC ACIDS; CYCLIN D1; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NITRIC OXIDE; NITRITES; PHOSPHORYLATION; RETINOBLASTOMA PROTEIN; SIGNAL TRANSDUCTION; UMBILICAL CORD;

EID: 21644457753     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20281     Document Type: Article

References (40)

1. Ahmed A, Dunk C, Kniss D, Wilkes M. 1997. Role of VEGF receptor-1 (Fit-1) in mediating calcium-dependent nitric oxide release and limiting DNA synthesis in human trophoblast cells. Lab Invest 76:779-791.
2. Boulton TG, Nye SH, Robbins DJ, Radziejewska E, Morgenbesser SD, DePhino RA, Panayotatos N, Cobb MH, Yancopoulos GD. 1991. ERKs: A family of protein serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 65:663-675.
3. Bourne L, Rice-Evans C. 1997. The effect of the phenolic antioxidant ferulic acid on the oxidation of low density Iipoprotein depends on the pro-oxidant used. Free Rad Res 27:337-344.
4. Cha MS, Lee MJ, Je GH, Kwak JY. 2001. Endogenous production of nitric oxide by vascular endothelial growth factor down-regulates proliferation of choriocarcinoma cells. Biochem Biophys Res Commun 282:1061-1066.
5. Eriksson K, Magnusson P, Dixelius J, Cross MJ. 2003. Angiostatin and endostatin inhibit endothelial cell migration in response to FGF and VEGF without interfering with specific intracellular signal transduction pathways. FEBS Lett 536:19-24.
6. Folkman J. 1995. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27-31.
7. Gartel AL, Tyner AL. 2002. The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther 1:639-649.
8. Han J, Bibbs L, Ulevitch RJ. 1994. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265:808-810.
9. Hiebert SW, Chellappen SP, Horowitz JM, Nevins JR. 1992. The interaction of RB with E2F coincides with inhibition of the transcriptional activity of E2F. Genes Dev 6:177-185.
10. Ingram AJ, James L, Cai L, Ly H, Scholey JW. 2000. NO inhibits stretch induced MAPK activity by cytoskeletal disruption. J Biol Chem 275:40301-40306.
11. Kimura H, Ogura T, Kurashima Y, Weisz A, Esumi H. 2002. Effects of nitric oxide donors on vascular endothelial growth factor gene induction. Biochem Biophy Res Commun 296:976-982.
12. Kyriakis J, Woodgett JR. 1994. The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369:156-160.
13. Lavoie JN, Allemain GL, Brunet A, Muller R, Pouyssegur J. 1996. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J Biol Chem 271:20608-20616.
14. Liu SM, Yu DH, Xu ZP, Riordan JF, Hu GF. 2001. Angiogenin activates Erk1/2 in human umbilical vein endothelial cells. Biochem Biophys Res Commun 287:305-310.
15. Lorenz M, Wessler S, Follmann E, Michaelis W, Düsterhöft T, Baumann G, Stangl K, Stang V. 2004. A constituent of green tea, epigallocatechin-3-gallate, activates endothelial nitric oxide synthase by a phosphatidylinositol-3-OH-kinase, cAMP dependent protein kinase, and akt-dependent pathway and leads to endothelial dependent vasorelaxation. J Biol Chem 279:6190-6195.
16. Ma J, Nakajima T, Iida H, Iwasawa K, Terasawa K, Oonuma H, Jo T, Morita T, Imuta H. 2003. Inhibitory effects of ursodeoxycholic acid on the induction of nitric oxide synthase in vascular smooth muscle cells. Eur J Pharmacol 464:79-86.
17. McCarthy MJ, Loftus IM, Thompson MM, Jones L, London NJ, Bell PR, Naylor AR, Brindle NP. 1999. Angiogenesis and the atherosclerotic carotid plaque: An association between symptomatology and plaque morphology. J Vasc Surg 30:261-268.
18. Morbidelli L, Chang CH, Douglas JG, Granger HJ, Ledda F, Ziche M. 1996. Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am J Physiol 270:411-415.
19. Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63.
20. Parenti A, Morbidelli L, Cui XL, Douglas JG, Hood JD, Granger HJ, Ledda F, Ziche M. 1998. Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase 1/2 activation in postcapillary endothelium. J Biol Chem 273:4220-4226.
21. Pepper MS. 1997. Manipulating angiogenesis. From basic science to the bedside. Arterioscler Thromb Vasc Biol 17:605-619.
22. Pintus G, Tadolini B, Posadino AM, Sanna B, Debidda M, Federico B, Sava G, Ventura C. 2002. Inhibition of the MEK/ERK signaling pathway by the novel antimetastatic agent NAMI-A down regulates c-myc gene expression and endothelial cell proliferation. Eur J Pharmacol 269:5861-5870.
23. 1/S transition. Cell Signal 14:751-759.
24. Raines KW, Cao GL, Porsuphatana S, Tsai P, Rosen GM, Shapiro P. 2004. Nitric oxide inhibition of ERK1/2 activity in cells expressing neuronal nitric-oxide synthase. J Biol Chem 279:3933-3940.
25. RayChaudhury A, Frischer H, Malik AB. 1996. Inhibition of endothelial cell proliferation and bFGF-induced phenotypic modulation by nitric oxide. J Cell Biochem 63:125-134.
26. Sarkar R, Gordon D, Stanley JC. 1997. Cell cycle effects of nitric oxide on vascular smooth muscle cells. Am J Physiol 272:1810-1818.
27. 1 phase progression: Cycling on cue. Cell 79:551-555.
28. Shin EY, Lee JY, Park MK, Chin YH, Kim SY, Kim SR, Kim EG. 1999. Overexpressed alphaSbetaland constitutively activated extracellular signal-regulated kinasemodulate the angiogenic properties of ECV304 cells. Mol Cell 9:138-145.
29. Su B, Karin M. 1996. Mitogen-activated protein kinase cascades and regulation of gene expression. Curr Opin Immunol 8:402-411.
30. Sylvie G, Bernier S, Thomas M. 2000. Bradykinin regulated interactions of the mitogen-activated protein kinase pathway with the endothelial nitric-oxide synthase. J Biol Chem 275:30707-30715.
31. Tanner FC, Yang ZY, Duckers E, Gordon D, Nabel GJ, Nabel EG. 1998. Expression of cyclin-dependent kinase inhibitors in vascular disease. Circ Res 82:396-403.
32. Waga S, Hannon GL, Beach D, Stillman B. 1994. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369:574-578.
33. Wang SF, Ou-Yang YP. 2003. Effect of sodium ferulate on human umbilical vein endothelial cell NOS genic expression induced by TNF-α. Microcirculation 13:28-30.
34. 1α. Kunming Med Coll 13:29-33.
35. Wei C. 2002. Sodium ferulate cure unstability of angina. J Chin Modern Med 12:77-78.
36. Weinberg RA. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330.
37. Yu H, Wu DF. 2002. Sodium ferulate protects human aortic smooth muscle cells against oxidized lipoprotein. J Chin Pathol 18:938-941.
38. Zhang JJ, Liu YM, Liu HX. 2001. Sodium ferulate protects against ischemia-reperfusion induced oxidative DNA damage in rat brain. Chin J Neurosci 17:198-200.
39. Zheng J, Bird IM, Melsaether AN, Magness RR. 1999. Activation of the mitogen-activated protein kinase cascade is necessary but not sufficient for basic fibroblast growth factor-and epidermal growth factor-stimulated expression of endothelial nitric oxide synthase in ovine fetoplacental artery endothelial cells. Endocrinology 140:1399-1407.
40. Zieske JD, Francesconi CM, Guo XQ. 2004. Cell cycle regulators at the ocular surface. Exp Eye Res 78:447-456.